The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((3-(4-(aminomethyl)phenyl)propyl)(methyl)amino)ethyl)naphthalene-2-sulfonamide ID: ALA415045
PubChem CID: 10112313
Max Phase: Preclinical
Molecular Formula: C23H29N3O2S
Molecular Weight: 411.57
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(CCCc1ccc(CN)cc1)CCNS(=O)(=O)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C23H29N3O2S/c1-26(15-4-5-19-8-10-20(18-24)11-9-19)16-14-25-29(27,28)23-13-12-21-6-2-3-7-22(21)17-23/h2-3,6-13,17,25H,4-5,14-16,18,24H2,1H3
Standard InChI Key: JHMVBRYMDMZHLU-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
7.3837 0.7681 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.9724 0.0568 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7984 1.4812 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0969 0.3533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0937 -0.4464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5367 0.3822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8452 0.7827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5370 -0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8224 -0.8695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8233 -1.6599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5440 -2.0806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2696 -1.6643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2733 -0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9512 -0.4532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6696 -0.0410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6732 0.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9570 1.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2380 0.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2342 -0.0485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4740 -0.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1779 -0.0434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3882 1.1927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0994 0.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8143 1.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5275 0.7769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2424 1.1871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9556 0.7725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6705 1.1828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5252 -0.0473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 2 0
1 4 1 0
4 5 2 0
5 9 1 0
8 6 1 0
6 7 2 0
7 4 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 8 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
19 20 1 0
20 21 1 0
16 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 1 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.57Molecular Weight (Monoisotopic): 411.1980AlogP: 3.14#Rotatable Bonds: 10Polar Surface Area: 75.43Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.15CX Basic pKa: 9.28CX LogP: 3.09CX LogD: 0.85Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.54Np Likeness Score: -1.14
References 1. Miyazaki Y, Kato Y, Manabe T, Shimada H, Mizuno M, Egusa T, Ohkouchi M, Shiromizu I, Matsusue T, Yamamoto I.. (2006) Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors., 16 (11): [PMID:16540315 ] [10.1016/j.bmcl.2006.02.064 ]